UPB Rega marang bathi mangsa ngarep Upstream Bio Inc
Upstream Bio Inc revenues are based on the upcoming market launch of UPB-101 antibodies for asthma. The company's forward P/E ratio reflects the business valuation trend, where the parameter is 0.00. Professional management strictly adheres to clinical trial discipline, and the development of the entire ecosystem currently depends entirely on FDA regulatory verdicts.
Upstream Pharma (UPB) - rincian metrik lan laporan keuangan
- kuotasi lan prakiraan analis:
- data kapitalisasi pasar:
- data ekuitas miturut neraca:
- indikator beban kredit lan likuiditas emiten:
Utang marang Ekuitas Upstream Bio Inc|UPB - Rasio utang jangka dawa marang modal|Utang jangka cendhak marang modal Upstream Bio Inc|UPB - Utang kumulatif perusahaan|Utang marang nilai buku Upstream Bio, Inc.|UPB - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Upstream Bio|Likuiditas cepet upstreambio.com
- indikator profitabilitas perusahaan lan kelipatan valuasi:
UPB - Asil keuangan resik|Bathi mangsa ngarep Upstream Bio Inc|UPB - Rasio rega pasar marang bathi resik|Rega marang bathi mangsa ngarep Upstream Bio Corp|UPB - Koefisien bali modal nimbang wutah|Pangali EV/EBITDA Upstream Bio, Inc.|UPB - Bathi sadurunge bunga, pajak, lan amortisasi|Bathi resik saben saham (EPS TTM) Upstream Bio|UPB - Bathi resik saben saham (EPS TTM)|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan upstreambio.com|UPB - Wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi saben saham kanggo taun ngarep Upstream Bio Inc
Analisis kabeh metrik perusahaan:Upstream Bio UPB
Forward P/E assesses the fairness of market value through the lens of projected earnings. Analyzing the forward price-to-earnings ratio of Upstream Bio Inc (UPB) on the GURU.Markets platform allows investors to filter out speculative noise from fundamental trends. The current value of 0.00 is driven by the ratio of market capitalization to expected net income. The metric's dynamics reflect market expectations for the commercialization of verequitumag. Inelastic demand for severe asthma therapy provides Upstream Bio Inc (UPB) with significant pricing power.
Analisis perusahaan pesaing
Pangali Forward P/E ARGX|Kapitalisasi marang proyeksi bathi BioNTech Inc.|Rega marang bathi mangsa ngarep abivax.com ABVX|ADMA - Prakiraan rega marang bathi|PTGX - Rega marang bathi mangsa ngarep|immunovant.com (IMVT) - Prakiraan rega marang bathi|KNSA (Kiniksa) - Prakiraan rega marang bathi|Grifols SA (GRFS) - Pangali Forward P/E|Rega marang bathi mangsa ngarep Adaptive Biotechnologies Corp|Rasio rega marang bathi mangsa ngarep CLDX (Celldex Corp)|Pangali Forward P/E AUPH|BCRX - Rasio prakiraan rega marang bathi|Vera Therapeutics - Prakiraan rega marang bathi|Pangali Forward P/E Dianthus Therapeutics Inc DNTH|PHVS - Rega marang bathi mangsa ngarep|Rasio rega marang bathi sing dikarepake ABCL|Tourmaline Bio, Inc. (TRML) - Rega marang bathi mangsa ngarep|PGEN - Kapitalisasi marang proyeksi bathi|Prakiraan rega marang bathi PHAR|NKTR (Nektar Therapeutics Inc) - Rasio kapitalisasi marang bathi mangsa ngarep|Rega marang bathi mangsa ngarep Zenas Biopharma, Inc. (ZBIO)|IMNM (Immunome Bio) - Pangali mangsa ngarep rega marang bathi|Pangali Forward P/E GOSS (Gossamer Bio, Inc.)|kalvista.com (KALV) - Rasio prakiraan rega marang bathi|Septerna - Pangali Forward P/E|PVLA - Pangali Forward P/E|Savara Corp (SVRA) - Rega marang bathi mangsa ngarep|Prakiraan rega marang bathi Rigel Corp|Prakiraan rega marang bathi ANAB|ATXS: Pangali mangsa ngarep rega marang bathi|Pangali Forward P/E ENGN|Rega marang bathi mangsa ngarep RAPT (RAPT Therapeutics Inc.)|Pangali Forward P/E JBIO (Aerovate Therapeutics)|Kapitalisasi marang proyeksi bathi Aclaris Therapeutics, Inc (ACRS)|KYTX - Rega marang bathi mangsa ngarep|Rasio prakiraan rega marang bathi tizianalifesciences.com|CABA (Cabaletta Bio) - Prakiraan rega marang bathi|Ventyx Biosciences Inc. - Pangali mangsa ngarep rega marang bathi|THTX (Theratechnologies Inc) - Pangali Forward P/E|Avalo Therapeutics Inc (AVTX) - Kapitalisasi marang proyeksi bathi|Rega marang bathi mangsa ngarep Eledon Pharmaceuticals (ELDN)|agenusbio.com - Rasio rega marang bathi mangsa ngarep|Pangali Forward P/E CLYM (Climb Bio)|ZURA - Prakiraan rega marang bathi|ATYR: Prakiraan rega marang bathi|ADAG - Pangali Forward P/E|ikenaoncology.com (IMA) - Rega marang bathi mangsa ngarep|Rasio rega marang bathi sing dikarepake STTK (Shattuck Labs)|EQ (Equillium Inc) - Pangali Forward P/E|Rega marang bathi mangsa ngarep CNTB|Rega marang bathi mangsa ngarep Immunic, Inc. (IMUX)|ATRA: Rasio rega marang bathi sing dikarepake|Pangali Forward P/E IFRX (InflaRx)|Pangali mangsa ngarep rega marang bathi XFOR|Adicet - Pangali Forward P/E|CELU - Pangali Forward P/E|INmune Bio Corp (INMB) - Rega marang bathi mangsa ngarep|Barinthus Biotherapeutics Corp - Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep Kezar Life Sciences|Prakiraan rega marang bathi sabbiotherapeutics.com (SABS)|Pangali Forward P/E AKTX|Pangali Forward P/E enlivex.com (ENLV)|Q32 Bio - Prakiraan rega marang bathi|Pangali mangsa ngarep rega marang bathi GOVX|Edesa Biotech, Inc. - Pangali Forward P/E|Kapitalisasi marang proyeksi bathi ibioinc.com IBIO|carismatx.com (CARM) - Rega marang bathi mangsa ngarep|Prakiraan rega marang bathi XTL Biopharmaceuticals Ltd|Rega marang bathi mangsa ngarep Bolt Biotherapeutics Inc.|Prakiraan rega marang bathi HCW Biologics Inc (HCWB)|Prakiraan rega marang bathi APVO (Aptevo Therapeutics)|Pangali Forward P/E AIM ImmunoTech, Inc. (AIM)|Rega marang bathi mangsa ngarep Aditxt, Inc. ADTX|GRI: Rasio rega marang bathi mangsa ngarep|XORTX - Pangali Forward P/E|Rasio prakiraan rega marang bathi Vyome Therapeutics|REVB (Revelation Biosciences) - Prakiraan rega marang bathi|indaptusrx.com (INDP) - Pangali Forward P/E|Rega marang bathi mangsa ngarep Scinai Immunotherapeutics Ltd.|CalciMedica Corp - Rasio rega marang bathi sing dikarepake|Rega marang bathi mangsa ngarep Affimed (AFMD)|Kapitalisasi marang proyeksi bathi allakos.com|HOOKIPA Pharma - Prakiraan rega marang bathi|Rasio kapitalisasi marang bathi mangsa ngarep IGMS (IGM Biosciences Inc.)|ITOS - Rega marang bathi mangsa ngarep|Pangali mangsa ngarep rega marang bathi OCEA (Ocean Biomedical Inc)|TCBP: Pangali Forward P/E|Rasio prakiraan rega marang bathi Third Harmonic Bio Inc (THRD)
